Aktsiaselts CHEMI-PHARM

Legal form:: Public limited company
Registry code:: 10140819
VAT no.:: EE100310771
Fiscal-year period:: 01.01 - 31.12
Established:: 16.04.1997 (29 y)
Capital:: 25 600 EUR
Address:: Tänassilma tee 11, Tänassilma küla, Saku vald, Harju maakond, 76406
Status:: Registered
E-invoice reception:: Telema

Follow changes

We notify you when the board, address or status changes or a tax debt appears.

Add to monitoring

Contacts

Phone:: +372 6778806
Email:: chemi-pharm@chemi-pharm.com
Website:: www.chemi-pharm.com

Data export

Create targeted sales lists in seconds

Choose the right criteria, export the data and start selling faster than ever!

Learn more

Industries

Industry TOPNo. 2 of 20 companies

1.Mayeri Industries AS39.1M €
2.Aktsiaselts CHEMI-PHARM19.7M €
3.Aktsiaselts ESTKO7.7M €
4.Nordic Group OÜ4.6M €
5.Goodpoint Chemicals OÜ2.8M €
6.Mulieres OÜ1.1M €
7.BALTIACHEMI OÜ511.8k €
8.Tahe OÜ342.9k €
9.OÜ Besur311.8k €
10.OmaGive OÜ116.7k €

Main activity 20411 · turnover over the last 4 quarters

All companies →

VAT liability

VAT no.	Start	End
EE100310771	01.05.1997	-

Annual reports

Aggregate data

Year	Period	Submitted	Status
2025	01.01.2025 – 31.12.2025	21.05.2026	Valid	PDF
2024	01.01.2024 – 31.12.2024	27.06.2025	Valid	PDF
2023	01.01.2023 – 31.12.2023	28.06.2024	Valid	PDF
2022	01.01.2022 – 31.12.2022	30.06.2023	Valid	PDF
2021	01.01.2021 – 31.12.2021	30.06.2022	Valid	PDF
2020	01.01.2020 – 31.12.2020	03.06.2021	Valid	PDF
2019	01.01.2019 – 31.12.2019	22.05.2020	Valid	PDF
2018	01.01.2018 – 31.12.2018	15.05.2019	Valid	PDF
2017	01.01.2017 – 31.12.2017	26.04.2018	Valid	PDF
2016	01.01.2016 – 31.12.2016	04.05.2017	Valid	PDF
2015	01.01.2015 – 31.12.2015	15.06.2016	Valid	PDF
2014	01.01.2014 – 31.12.2014	25.06.2015	Valid	PDF
2013	01.01.2013 – 31.12.2013	12.06.2014	Valid	PDF
2012	01.01.2012 – 31.12.2012	29.05.2013	Valid	PDF
2011	01.01.2011 – 31.12.2011	15.06.2012	Valid	PDF
2010	01.01.2010 – 31.12.2010	15.06.2011	Valid	PDF
2009	01.01.2009 – 31.12.2009	18.06.2010	Valid	PDF
2008	01.01.2008 – 31.12.2008	29.06.2009	Valid	PDF
2007	01.01.2007 – 31.12.2007	26.06.2008	Valid	PDF
2006	01.01.2006 – 31.12.2006	28.06.2007	Valid	PDF
2005	01.01.2005 – 31.12.2005	30.06.2006	Valid	PDF
2004	01.01.2004 – 31.12.2004	21.06.2005	Valid	PDF
2003	01.01.2003 – 31.12.2003	15.06.2004	Valid	PDF
2002	01.01.2002 – 31.12.2002	30.06.2003	Valid	PDF
2001	01.01.2001 – 31.12.2001	27.06.2002	Valid	PDF
2000	01.01.2000 – 31.12.2000	26.06.2001	Valid	PDF

Unsubmitted declarations

No unsubmitted declarations found

No unsubmitted declarations as of 23.10.2026.

Check company creditworthiness in seconds

Detailed reviews of company financial risks and strengths

3€ /monthGet started

Tax debt Reports Declarations Court decisions–Official announcements3 TTJA decisions–Real estate–.ee domains3 Licenses1 Regulations21 Public transactions8555 Grants43 State aid68 Public procurement308 Holdings in companies2 Enforcement proceedings Payment orders

Tax data

Period	State taxes	Labour taxes	Taxable turnover	Employees
2026 Q3	403 559 €	367 377 €	5,04 M €−1,1%	73
2026 Q2	210 855 €	326 073 €	5,10 M €+8,2%	75
2026 Q1	299 087 €	402 051 €	4,71 M €−3,3%	75
Total 2026:	913 501 €	1,10 M €	14,9 M €
2025 Q4	233 611 €	334 227 €	4,88 M €+21,3%	73
2025 Q3	312 457 €	351 044 €	4,02 M €−6,9%	75
2025 Q2	308 870 €	323 169 €	4,32 M €+4,8%	72
2025 Q1	267 598 €	361 951 €	4,12 M €−3,1%	74
Total 2025:	1,12 M €	1,37 M €	17,3 M €
2024 Q4	0 €	305 916 €	4,26 M €+17,8%	66
2024 Q3	33 924 €	274 456 €	3,61 M €−9,0%	65
2024 Q2	173 598 €	279 548 €	3,97 M €−3,1%	62
2024 Q1	191 855 €	293 388 €	4,10 M €+4,3%	64
Total 2024:	399 377 €	1,15 M €	15,9 M €
2023 Q4	205 825 €	248 835 €	3,93 M €+18,1%	67
2023 Q3	247 503 €	260 676 €	3,33 M €−6,5%	59
2023 Q2	205 227 €	266 320 €	3,56 M €+0,6%	62
2023 Q1	141 005 €	289 445 €	3,54 M €+1,7%	65
Total 2023:	799 560 €	1,07 M €	14,3 M €
2022 Q4	303 212 €	284 355 €	3,48 M €−1,5%	70
2022 Q3	315 031 €	292 657 €	3,53 M €−24,6%	72
2022 Q2	309 400 €	300 260 €	4,68 M €+12,4%	77
2022 Q1	307 697 €	313 110 €	4,17 M €−15,1%	79
Total 2022:	1,24 M €	1,19 M €	15,9 M €
2021 Q4	322 686 €	279 983,54 €	4,91 M €+34,8%	78
2021 Q3	373 203,70 €	294 336,56 €	3,64 M €−22,2%	79
2021 Q2	468 222,93 €	291 190,35 €	4,68 M €−11,7%	86
2021 Q1	151 773,98 €	314 381,50 €	5,30 M €−13,8%	87
Total 2021:	1,32 M €	1,18 M €	18,5 M €
2020 Q4	72 451,23 €	249 035,83 €	6,14 M €+5,7%	89
2020 Q3	201 702,67 €	245 091,57 €	5,81 M €−1,1%	75
2020 Q2	273 525,05 €	227 056,01 €	5,87 M €+163%	61
2020 Q1	129 032 €	173 885 €	2,24 M €+16,0%	56
Total 2020:	676 710,95 €	895 068,41 €	20,1 M €
2019 Q4	68 831 €	155 626 €	1,93 M €+15,2%	51
2019 Q3	99 802 €	161 059 €	1,67 M €+15,6%	65
2019 Q2	67 086 €	157 019 €	1,45 M €−24,0%	60
2019 Q1	154 237 €	154 178 €	1,90 M €+38,1%	52
Total 2019:	389 956 €	627 882 €	6,95 M €
2018 Q4	128 642 €	129 325 €	1,38 M €+4,2%	52
2018 Q3	140 438 €	141 491 €	1,32 M €−4,0%	52
2018 Q2	134 810 €	132 195 €	1,38 M €+3,3%	57
2018 Q1	156 456 €	140 029 €	1,33 M €+8,4%	54
Total 2018:	560 346 €	543 040 €	5,41 M €
2017 Q4	124 921 €	123 021 €	1,23 M €−17,5%	55
2017 Q3	151 901 €	134 972 €	1,49 M €+17,7%	48
2017 Q2	125 178 €	115 229 €	1,27 M €+9,8%	50
2017 Q1	121 158 €	112 700 €	1,15 M €+19,8%	43
Total 2017:	523 158 €	485 922 €	5,14 M €
2016 Q4	113 614 €	99 210 €	963 486 €−10,8%	1
2016 Q3	129 994 €	111 176 €	1,08 M €+12,3%	1
2016 Q2	109 995 €	98 958 €	961 039 €−7,6%	1
2016 Q1	162 687 €	107 094 €	1,04 M €+16,5%	1
Total 2016:	516 290 €	416 438 €	4,04 M €
2015 Q4	113 449 €	94 564 €	892 997 €−6,0%	1
2015 Q3	111 210 €	100 652 €	950 481 €+3,7%	1
2015 Q2	97 439 €	97 067 €	916 629 €+1,0%	1
2015 Q1	111 630 €	96 067 €	907 188 €	1
Total 2015:	433 728 €	388 350 €	3,67 M €

Revenue by industry

	2023	2024	2025
Manufacture of soap, detergents, cleaning and polishing preparations	10 424 276 €	12 557 282 €	13 959 069 €
Manufacture of perfumes and toilet preparations		568 146 €	575 968 €
Non-specialised wholesale trade	376 428 €	441 622 €	489 639 €
All other professional, scientific and technical activities n.e.c.		272 056 €	338 014 €
Manufacture of pharmaceutical preparations		162 309 €	107 449 €
Manufacture of medicines and other pharmaceutical products	421 390 €
Other professional, scientific and technical activities n.e.c.	229 474 €

Tax debts

No tax debt found

No tax debt as of 23.10.2026

Representatives

	Personal ID code
Reza Yeganeh Khonsari	38105XXXXXX	28.05.1981 (45)	Board member	07.09.2023	-
Ruth Oltjer	45910XXXXXX	22.10.1959 (67)	Board member	16.04.1997	-

31 inactive records hidden, extended access to the information portal is required to view history!

3€ /monthGet started

Shareholders

	Personal ID code
Chemi-Pharm holding OÜ	16694950	14.03.2023 (3)	Shareholder	17 920 EUR	70,00%	Sole ownership	16.08.2023	-
Chemilex OÜ	16673409	09.02.2023 (3)	Shareholder	7 680 EUR	30,00%	Sole ownership	16.08.2023	-

31 inactive records hidden, extended access to the information portal is required to view history!

3€ /monthGet started

Other persons

	Personal ID code
Andres Oltjer	35803XXXXXX	04.03.1958 (68)	Chairman of the supervisory board	11.12.2024	-
Britta Oltjer-Jaadla	48209XXXXXX	09.09.1982 (44)	Supervisory-board member	11.12.2024	-
Gretta Oltjer-Timberg	48905XXXXXX	21.05.1989 (37)	Supervisory-board member	11.12.2024	-
Merle Vacker	47002XXXXXX	19.02.1970 (56)	Supervisory-board member	11.12.2024	-
Ivari Koppel	38406XXXXXX	12.06.1984 (42)	Supervisory-board member	05.10.2023	-

31 inactive records hidden, extended access to the information portal is required to view history!

3€ /monthGet started

Ultimate beneficial owners

	Personal ID code
Andres Oltjer	35803XXXXXX	04.03.1958 (68)	Indirect holding	20.07.2021	-
Ruth Oltjer	45910XXXXXX	22.10.1959 (67)	Direct holding	19.10.2018	-

31 inactive records hidden, extended access to the information portal is required to view history!

3€ /monthGet started

Holdings in companies


Osaühing ROSTHERNE	08.05.1998	Shareholder	2 556 EUR	100,00%	Sole ownership	01.09.2023	-
PK Technologies OÜ	29.09.2021	Shareholder	255,60 EUR	10,22%	Sole ownership	01.09.2023	-

7 inactive records hidden, extended access to the information portal is required to view history!

3€ /monthGet started

2026 Q3

Turnover

Amount: 5 044 980 €
Monthly average: 1 681 660 €
Per employee: 23 036 €
Equity ratio: 6 568,98%

Labour taxes

Turnover ratio: 7,28%
Tax ratio: 91,03%
Monthly average: 122 459 €
Per employee: 1 655 €

State taxes

Monthly average: 134 520 €
Turnover ratio: 8,00%

Estimated salary

Gross salary: 3 015 €
Net salary: 2 421 €

Aggregate data

Last 5 yrsAll

	2025	2024	2023	2022	2021	2020	2019
Current assets	-	-	4 954 961 €−2,1%	5 060 763 €−51,9%	10 510 739 €+45,9%	7 203 245 €+193%	2 458 488 €
Non-current assets	-	-	8 903 529 €−25,2%	11 910 068 €+39,6%	8 532 825 €+304%	2 109 975 €+9,0%	1 935 590 €
Total assets	14 724 960 €+2,3%	14 393 595 €+3,9%	13 858 490 €−18,3%	16 970 832 €−10,9%	19 043 564 €+104%	9 313 220 €+109%	4 463 618 €
Short-term liabilities	-	-	1 625 352 €−16,8%	1 952 727 €−46,5%	3 653 337 €+216%	1 157 472 €+98,0%	584 634 €
Long-term liabilities	-	-	6 284 314 €−2,1%	6 418 206 €+1,3%	6 332 782 €+5 130%	121 085 €−35,1%	186 499 €
Total liabilities	-	-	7 909 666 €−5,5%	8 370 933 €−16,2%	9 986 119 €+681%	1 278 557 €+65,8%	771 133 €
Share or stock capital	-	-	25 600 €	25 600 €	25 600 €	25 600 €	25 600 €
Retained earnings	-	-	5 871 740 €−34,1%	8 909 289 €+17,2%	7 601 935 €+122%	3 423 862 €+4,2%	3 284 957 €
Net profit	-	-	48 928 €+114%	-337 547 €−124%	1 427 354 €−68,9%	4 582 645 €+3 043%	145 812 €
Equity	-	-	5 948 824 €−30,8%	8 599 898 €−5,1%	9 057 445 €+12,7%	8 034 663 €+125%	3 573 760 €
Turnover	-	-	11 451 568 €−11,0%	12 868 974 €−17,0%	15 495 778 €−16,1%	18 479 364 €+169%	6 859 249 €
Profit margin	-	-	0,4%	-2,6%	9,2%	24,8%	2,1%

Financial ratios

	2022	2021
Profit and cash flow
EBITDA	654 467 €	2 330 846 €
Liquidity
Current ratio	2,6	2,9
Quick ratio	0,9	1,9
Cash ratio	0,1	1,3
Efficiency
Days sales outstanding (dso)	185,3	94,2
Asset turnover	0,7	1,1
Structure
Debt ratio	0,5	0,5
Profitability
Operating margin	-1,3%	10,7%
Net profit margin	-2,6%	9,2%
Return on assets (roa)	-1,9%	10,1%
Return on equity (roe)	-3,9%	15,8%

Data export

These figures for over 281,000 companies, in one table

Revenue, EBITDA, ROE, ROA and other ratios
Up to five years of reports at once
Excel, CSV or JSON, updated daily

See how it works

To view all financial ratios, you need to subscribe to extended access to the info portal!

3€ /monthGet started

Licences & notices


License	SLV20/5879	Frequency licences	Valid	16.11.2020	15.11.2023

Regulations


Ä 10012152 / M6	26.09.2023	Order to remedy deficiencies – Amendment entry	14.10.2023	Deficiencies remedied06.10.2023
Ä 10012152 / 18	07.09.2023	Entry – Amendment entry	-	Entered into force07.09.2023
Ä 10012152 / 17	12.07.2023	Entry – Amendment entry	-	Entered into force12.07.2023
Ä 10012152 / 16	31.05.2023	Entry – Division entry of transferring entity (second, constitutive entry)	-	Entered into force31.05.2023
Ä 10012152 / M5	22.11.2021	Order to remedy deficiencies – Amendment entry	07.12.2021	Deficiencies remedied24.11.2021

Real estate

No real estate found

Company has no real estate

Consumer Disputes Committee decisions

No consumer dispute committee decisions found

Company has not been issued consumer dispute committee decisions

Court decisions

No court decisions found

The company has no court decisions

Official announcements


Notice of division of a company	01.06.2023	PDF
Notice of division of a company	01.06.2023	PDF
Notice of preparation of a division plan or conclusion of a division agreement	13.04.2023	PDF

Public transactions


30.09.2026	AS Lõuna-Eesti Haigla	604,26 €Received	OPERATING EXPENSESGeneral hospital services
29.09.2026	Sihtasutus Ida-Viru Keskhaigla	1 531,15 €Received	OPERATING EXPENSESGeneral hospital services
29.09.2026	Maarjamaa Riigikool	130,73 €Received	OPERATING EXPENSESBasic and general secondary education
29.09.2026	Aktsiaselts Rakvere Haigla	304,62 €Received	OPERATING EXPENSESGeneral hospital services
29.09.2026	Aktsiaselts Rakvere Haigla	73,11 €Received	OPERATING EXPENSESGeneral hospital services

Funded projects


Chemi-Pharm tootmisprotsessi ressursitõhususe suurendamine2021-2027.2.04.26-0545	(EK nr 2.6) Ring- ja ressursitõhusale majandusele ülemineku edendamineCF · Sihtasutus Keskkonnainvesteeringute Keskus	01.06.2026 – 31.12.20262021-2027	169 050 €support 65,0%	-	Funded
AS Chemi-Pharm jätkusuutlikkuse projekt20.2.01.25-0208	Rohepöörde kiirendamineRRF · Ettevõtluse ja Innovatsiooni Sihtasutus	01.06.2025 – 31.05.20262020-2026	436 344,05 €support 26,6%	366 051,53 €	Completed
Ettevõtte Cargoson veohaldustarkvara ja Cargoson eFTI platvormi vaheline liidestamine20.1.01.25-1302	Majanduse digipöörde toetamineRRF · Ettevõtluse ja Innovatsiooni Sihtasutus	26.05.2025 – 30.09.20252020-2026	10 200 €support 90,0%	10 200 €	Completed
AS Chemi-Pharmi roheaudit20.2.01.24-0186	Rohepöörde kiirendamineRRF · Ettevõtluse ja Innovatsiooni Sihtasutus	06.01.2025 – 21.02.20252020-2026	7 980 €support 50,0%	7 800 €	Completed
AS Chemi-Pharm digipööre 2025 etapp II20.1.01.24-0749	Majanduse digipöörde toetamineRRF · Ettevõtluse ja Innovatsiooni Sihtasutus	01.10.2024 – 30.11.20252020-2026	230 000 €support 50,0%	217 005,62 €	Completed

State aid


28.09.2026	Ettevõtluse ja Innovatsiooni SihtasutusAid measure 262119	Muu › MuuGrant	5 000 €	262119/2600002
12.06.2026	SA Keskkonnainvesteeringute KeskusAid measure 251914	Keskkonnakaitse (VTA) › MuuGrant	109 882,50 €	251914/2600031
19.01.2026	Eesti TöötukassaAid measure 231580	Palgatoetus VTA › Palgatoetus VTAGrant	677,28 €	231580/2600440
26.08.2025	Ettevõtluse ja Innovatsiooni SihtasutusAid measure 221443	Muu › MuuGrant	22 047,16 €	221443/2500033
26.08.2025	Ettevõtluse ja Innovatsiooni SihtasutusAid measure 241664	EK grupierandi määrus 651/2014 Teadus- ja arendustegevuseks ning innovatsiooniks antav abi (artiklid 25-30) › Protsessi- ja organisatsiooniinnovatsiooniks antav abi (artikkel 29)Grant	15 730,13 €	241664/2500010

Public procurement contracts


24.09.2026End 25.09.2028	Reference number 310936 · Müügilepingu raamleping (Aktsiaselts CHEMI-PHARM)	Eesti MaaülikoolContracting authority	1 000 000 €	Concluded
29.07.2026End 28.07.2028	Reference number 309901 · Raamleping_Aktsiaselts CHEMI-PHARM	Aktsiaselts Ida-Tallinna KeskhaiglaContracting authority	224 840 €	Concluded
27.06.2026End 01.04.2028	Reference number 307620 · Raamleping Aktsiaselts CHEMI-PHARM 1.08/A/407-20	Aktsiaselts Rakvere HaiglaContracting authority	840 €	Concluded
10.06.2026End 09.06.2029	Reference number 307217 · Raamleping 27, 28, 29, 35, 36, 37, 38, 39, 42	sihtasutus Tartu Ülikooli KliinikumContracting authority	144 903,20 €	Concluded
10.06.2026End 09.06.2029	Reference number 307217 · Raamleping 32, 34	sihtasutus Tartu Ülikooli KliinikumContracting authority	686,40 €	Concluded

.ee domains


medihex.ee	Active	03.11.2020	04.11.2027
chemi-pharm.ee	Active	25.03.2019	26.03.2027
ddifference.ee	Active	21.10.2014	22.10.2027

Enforcement proceedings

No enforcement proceedings found

Company has no active debts with bailiffs

Payment orders

No payment orders found

Company has no court-ordered payment orders

Data comes from public registers.